Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme
C Twelves, M Campone, B Coudert, et al.
Clinical Pharmacology and Therapeutics
|
December 17, 2008
A dynamic model of hand-and-foot syndrome in patients receiving capecitabine
E Hénin, B You, E VanCutsem, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 1999
Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients
J Cassidy, C Twelves, D Cameron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2002
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
L Biganzoli, T Cufer, P Bruning, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer
F Efficace, L Biganzoli, M Piccart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer
H J Mackay, M Hill, C Twelves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group
P Schöffski, S Riggert, P Fumoleau, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A R Clamp, P Schöffski, J W Valle, et al.
British Journal of Cancer
|
November 21, 1998
A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion
L Paz-Ares, R Kunka, D DeMaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 1999
Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion
J P Stevenson, D DeMaria, J Sludden, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme
C Twelves, M Campone, B Coudert, et al.
Clinical Pharmacology and Therapeutics
|
December 17, 2008
A dynamic model of hand-and-foot syndrome in patients receiving capecitabine
E Hénin, B You, E VanCutsem, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 1999
Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients
J Cassidy, C Twelves, D Cameron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2002
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
L Biganzoli, T Cufer, P Bruning, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer
F Efficace, L Biganzoli, M Piccart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer
H J Mackay, M Hill, C Twelves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 20, 2004
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group
P Schöffski, S Riggert, P Fumoleau, et al.
Cancer Chemotherapy and Pharmacology
|
May 24, 2007
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A R Clamp, P Schöffski, J W Valle, et al.
British Journal of Cancer
|
November 21, 1998
A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion
L Paz-Ares, R Kunka, D DeMaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 1999
Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion
J P Stevenson, D DeMaria, J Sludden, et al.
Page
of 8